Search

Search Language

italiano / Italian | Use language selector above (below, on mobile) to search additional languages

Open filter

Selected filters
x(Life Sciences & HealthTech)

35 items matching filters

Insight

UK: Biometric Technologies – An Early Warning and Picture of the Way Forwards from the ICO

by Kelly Hagedorn and Anna O'Kelly | March.23.2023

Kelly Hagedorn and Anna O'Kelly explore the ICO's perspective on biometric technologies, their potential, risks, and regulatory avenues for the future

Insight

DAOs Might Be Cure for Biotech Startups and New Drug Development

by Joseph Perkins and Stephen Thau | January.17.2023

Joseph Perkins and Stephen Thau explain how early-stage biotech startups can use DAOs to provide an alternative to traditional sources of capital.

Insight

OLNS#10: University Entrepreneurship & Spin-offs in Germany – Set-up / IP / Financing and Much More

November.15.2022

German universities increasingly are becoming entrepreneurial hotbeds, though university spin-offs face unique challenges.

Insight

Life Sciences Collaboration Deals a Mainstay of Biotech Industry – Here Are the Tax Consequences

October.21.2022

Two of our partners and an Andersen director author Law360 article on tax implications in LSC collaboration deals.

Insight

EU and U.S. Privacy and Security Considerations for COVID-19 Data Processing Activities from Pandemic to Living With COVID

by Thora Johnson | August.10.2022

EU & US Privacy and Security Considerations for Covid-19 Data Processing Activities From Pandemic to Living with Covid written by Thora Johnson.

Insight

Newsweek: The Next Frontier of the Fight for Abortion Rights is Privacy Law

by Thora Johnson and Alyssa Wolfington | July.28.2022

Our lawyers wrote Newsweek opinion piece calling for federal legislation to address privacy vulnerabilities after Dobbs.

Insight

Health Tech Companies Should Prepare for New Information Blocking Rules to Ensure Compliance

by Thora Johnson | September.27.2021

We analyze new rules prohibiting information blocking rules for health tech companies and outline steps they can take to ensure compliance.

Insight

Royalty Licensing Insurrection in Life Sciences

by David Schulman and Alyssa Barnard-Yanni | July.19.2021

Orrick’s David Schulman and Alyssa Barnard-Yanni have co-authored an article in Intellectual Property magazine that discusses the recent fallout from ...

Insight

Using M&A Insurance on Tech Deals (Issue 3): Fintech, edtech and healthtech/medtech

by David M. Ruff, Hari Raman, Daniel Lopez and Zac Padgett | January.21.2021

We dig deeper into key underwriting topics for fintech, edtech and healthtech/medtech deals.

Insight

Chinese and Russian Hackers Targeting COVID-19 Vaccine Research

August.04.2020

The latest development in the Department of Justice’s “China Initiative” occurred earlier this month, as the DOJ unsealed an 11-count indictment ...

Insight

17 Mistakes Startups Make with Their Investor Pitch Deck

July.29.2019

Orrick’s Technology and Life Sciences Sector Leader Don Keller co-authored an article in Forbes with Orrick alum Richard Harroch.

Insight

Profiles in Innovation: Twist Bioscience’s Co-Founder Navigates Company from Start-up to Public Company

February.21.2019

Emily Leproust discusses her inspiration and journey building a public company in the fast growing synthetic DNA market with commentary from Orrick ...